I. Tikkanen et al., INCREASED SERUM NEUTRAL ENDOPEPTIDASE ACTIVITY IN ACUTE RENAL-ALLOGRAFT REJECTION, American journal of nephrology, 16(4), 1996, pp. 273-279
Neutral endopeptidase (EC 3.4.24.11; NEP), originally isolated from re
nal tubular brush border, is a cell surface peptidase identical to the
CD 10 antigen (or CALLA; common acute lymphoblastic leukemia antigen)
in lymphoid cells. We studied the serum NEP levels daily after transp
lantation (Tx) in 19 renal allograft recipients. The NEP activity was
determined with a two-step enzymatic assay utilizing a fluorogenic sub
strate (Suc-Ala-Ala-Phe-AMC; see text) and related to clinical signs o
f graft rejection, to signs of immunoactivation in transplant fine-nee
dle aspiration biopsy (FNAB) specimens, to renal function, and to seru
m levels of C-reactive protein. The serum NEP levels remained normal (
peak level 10.3 +/- 1.8 mu g/l on days 6-9 after Tx, initial level aft
er Tx 7.3 +/- 1.4 mu g/l on day 2; mean values +/- SEM) in patients wh
o neither showed clinical signs of rejection nor had findings of immun
oactivation in FNAB samples. On the contrary, the serum NEP levels ros
e clearly in patients developing acute rejection verified clinically a
nd in FNAB samples (peak value 90.4 +/- 18.7 mu g/l on days 6-9 post-T
x; p < 0.001 compared with patients without signs of immunoactivation)
and even in patients having immunoactivation in FNAB without clinical
evidence of rejection (108.2 +/- 22.4 mu g/l, p < 0.001). Serum NEP p
eak appeared 2-3 days before clinical diagnosis of rejection and a pos
itive finding in FNAB samples. Serum NEP increments did not correlate
with changes in serum creatinine, delayed onset of renal excretory fun
ction, blood leukocyte count, C-reactive protein level, or infections.
Thus, the serum NEP activity was shown to increase after renal allotr
ansplantation associated with early phases of immunoactivation and dev
elopment of acute graft rejection. Because of the limited number of pa
tients studied, the clinical implications of these preliminary observa
tions for kidney transplant monitoring clearly need confirmation in la
rger studies.